A Comparison of Abciximab and Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Primary Percutaneous Coronary Intervention: A Meta-Analysis of Contemporary Randomized Controlled Trials
Circulation: Cardiovascular Interventions - United States
doi 10.1161/circinterventions.108.847996
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2009
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)